1 / 8

Viral Vector & Plasmid DNA Manufacturing Market Analysis, Emerging Technology

The viral vector & plasmid DNA manufacturing market is expected to reach US$ 2,247.7 million by2027 from US$ 459.4million in 2019. The market is estimated to grow with a CAGR of 22.1% from 2020 to 2027.<br>

Alex832
Download Presentation

Viral Vector & Plasmid DNA Manufacturing Market Analysis, Emerging Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Viral Vector & Plasmid DNA Manufacturing Market Global Trends, Size, Segments and Growth till 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Viral Vector & Plasmid DNA Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Viral Vectors, Non-viral Vectors); Application (Cancer, Inherited Disorders, Viral Infections, Others), and Geography

  3. Email:sales@theinsightpartners.com Viral Vector & Plasmid DNA Manufacturing MarketOverview • The Viral Vector & Plasmid DNA Manufacturing Marketis expected to reach US$ 2,247.7 million by2027 from US$ 459.4million in 2019. The market is estimated to grow with a CAGR of 22.1% from 2020 to 2027. • The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. The report highlights trends prevailing in the global viral vector & plasmid DNA manufacturing market and the factors driving market along with those that act as hindrances.Based on Product, the global viral vector & plasmid DNA manufacturing market is segmented into viral vectors and non-viral vectors. The viral vectors segment held the largest share of the market in 2019owing to the rising preference for viral vectors in gene transfer is evident by the increase in number of clinical trials on viral vector-mediated gene therapy and rising in number of initiative taken by market players.

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Viral Vectors, Non-Viral Vectorsand Others) • Application (Cancer, Inherited Disorders, Viral Infections, Others) Download Sample

  5. Email:sales@theinsightpartners.com Viral Vector & Plasmid DNA Manufacturing Market Value CAGR of 22.1% (2020 - 2027) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Brammer Bio • Sanofi • FUJIFILM Diosynth Biotechnologies • Cell and Gene Therapy Catapult • Cobra Biologics • FinVector • Kaneka Eurogentec S.A. • MassBiologics • Spark Therapeutics • Uniqure Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related